Shots:
Endevica Bio conducting P-II study in collaboration with WuXi Clinical reported the dose administration of B07 in first patient to prevent weight loss in cancer patients diagnosed with stage 4 metastatic colorectal cancer undergoing CT
In 2024, Endevica Bio completed its P-I study, with early results showing strong safety and efficacy. In current P-II…
